Search
Biotherapeutic_Technologies_Flyer_BIO_2022.pdf
Biotherapeutics Modalities Infographic FINAL.pdf
the agenda.pdf
Netherton-syndrome-unmet-needs-infographic
2023 Moving towards a rabies-free Southeast Asia_Whitepaper.pdf
Partnering in Biotherapeutics Technologies MARCH 2023 Corporate
Partnering in Biotherapeutics Technologies MARCH 2023 Corporate
Partnering in Biotherapeutics MAY 2023 Corp
Partnering in Biotherapeutics JUNE 2023 CORP
Prevalence of VTE in the US and Europe.pdf
Partnering Day France Flyer Save the date 2018 08 02.pdf
How AF affects the heart.pdf
The Economic Burden of VTE.pdf
The Global Cardiovascular Disease Burden.pdf
The Global Cardiovascular Disease Burden.pdf
The Economic Burden of VTE.pdf
How AF can affect the heart beat.pdf
How AF can affect the heart beat.pdf
How AF can affect the heart beat.pdf
Praxbind® – the specific reversal agent to dabigatran.pdf
add-on_therapy_Moroni-Zentgraf.pdf
Partnership to Develop Urea Cycle Disorders Therapy
Boehringer Ingelheim Partners with Thoeris to Investigate a Novel Approach to Treat Urea Cycle Disorders
Lady, a guide dog in the office
A great partnership between a Boehringer Ingelheim employee and her guide dog at work. Their relationship goes beyond the human-animal bond.
Catherine Alonzo
Catherine Alonzo, Patient Safety Physician, Metabolism, tells us about the importance of drug surveillance.